{
  "ticker": "NKTR",
  "company_name": "Nektar Therapeutics",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03435640",
      "title": "REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Renal Cell Carcinoma, Colorectal Cancer, Sarcoma",
      "start_date": "2018-03-15",
      "completion_date": "2022-05-09",
      "enrollment": 0,
      "sponsor": "Nektar Therapeutics"
    },
    {
      "nct_id": "NCT01492101",
      "title": "The BEACON Study (Breast Cancer Outcomes With NKTR-102)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Locally Recurrent Breast Cancer, Metastatic Breast Cancer",
      "start_date": "2011-12",
      "completion_date": "2016-06",
      "enrollment": 0,
      "sponsor": "Nektar Therapeutics"
    },
    {
      "nct_id": "NCT01799993",
      "title": "Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pneumonia, Bacterial",
      "start_date": "2013-04-13",
      "completion_date": "2017-04-07",
      "enrollment": 0,
      "sponsor": "Bayer"
    },
    {
      "nct_id": "NCT03635983",
      "title": "A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Melanoma",
      "start_date": "2018-09-21",
      "completion_date": "2024-03-19",
      "enrollment": 0,
      "sponsor": "Bristol-Myers Squibb"
    },
    {
      "nct_id": "NCT05359211",
      "title": "NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma, Recurrent Primary Mediastinal Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory Grade 3b Follicular Lymphoma, Refractory Primary Mediastinal Large B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma",
      "start_date": "2022-12-08",
      "completion_date": "2026-09-04",
      "enrollment": 0,
      "sponsor": "Fred Hutchinson Cancer Center"
    },
    {
      "nct_id": "NCT01991678",
      "title": "A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment",
      "start_date": "2013-11",
      "completion_date": "2017-09",
      "enrollment": 0,
      "sponsor": "Nektar Therapeutics"
    },
    {
      "nct_id": "NCT03772288",
      "title": "A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL)",
      "status": "WITHDRAWN",
      "phase": "PHASE1",
      "condition": "Lymphoma, Non-Hodgkin",
      "start_date": "2019-04-03",
      "completion_date": "2021-11-17",
      "enrollment": 0,
      "sponsor": "Calithera Biosciences, Inc"
    },
    {
      "nct_id": "NCT04969861",
      "title": "BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)",
      "status": "TERMINATED",
      "phase": "PHASE2, PHASE3",
      "condition": "Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer",
      "start_date": "2022-03-09",
      "completion_date": "2022-04-22",
      "enrollment": 0,
      "sponsor": "Nektar Therapeutics"
    },
    {
      "nct_id": "NCT01876446",
      "title": "Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Recurrent Small Cell Lung Carcinoma",
      "start_date": "2013-08-29",
      "completion_date": "2020-02-24",
      "enrollment": 0,
      "sponsor": "Roswell Park Cancer Institute"
    },
    {
      "nct_id": "NCT03729245",
      "title": "A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma",
      "start_date": "2018-12-18",
      "completion_date": "2022-10-19",
      "enrollment": 0,
      "sponsor": "Nektar Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1, PHASE2": 8,
      "PHASE3": 8,
      "PHASE1": 16,
      "PHASE2, PHASE3": 2,
      "PHASE2": 16
    },
    "by_status": {
      "TERMINATED": 12,
      "COMPLETED": 33,
      "ACTIVE_NOT_RECRUITING": 3,
      "WITHDRAWN": 2
    },
    "active_trials": 3,
    "completed_trials": 33,
    "conditions": [
      "Advanced Cancer",
      "Advanced Cancer, Metastatic Solid Tumors",
      "Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment",
      "Alopecia Areata",
      "Anaplastic Astrocytomas, Anaplastic Oligodendrogliomas, Glioblastomas (GBM)",
      "Colitis, Ulcerative",
      "Colorectal Cancer",
      "Dermatitis, Atopic",
      "Diabetes Mellitus, Type 2",
      "Ependymoma, Ewing Sarcoma, High-grade Glioma, Leukemia and Lymphoma, Medulloblastoma, Miscellaneous Brain Tumors, Miscellaneous Solid Tumors, Neuroblastoma, Relapsed, Refractory Malignant Neoplasms, Rhabdomyosarcoma",
      "Head and Neck Cancer",
      "Head and Neck Squamous Cell Carcinoma, Colorectal Cancer",
      "Healthy",
      "Locally Advanced or Metastatic Solid Tumours",
      "Locally Recurrent Breast Cancer, Metastatic Breast Cancer",
      "Low Back Pain, Chronic Pain",
      "Lymphoma, Non-Hodgkin",
      "Malignant Solid Tumor",
      "Melanoma",
      "Melanoma, Melanoma Stage III, Melanoma Stage IV, Melanoma (Skin)",
      "Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma, Renal Cell Carcinoma, Colorectal Cancer, Sarcoma",
      "Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer, Urothelial Carcinoma, Triple Negative Breast Cancer, HR+/HER2- Breast Cancer, Gastric Cancer",
      "Metastasis, Breast Cancer",
      "Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer",
      "Metastatic Melanoma",
      "Metastatic Non Small Cell Lung Cancer",
      "Moderate to Severe Atopic Dermatitis",
      "Moderate to Severe Chronic Pain",
      "Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma",
      "Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma",
      "Non-Small Cell Lung Cancer",
      "Opioid Induced Constipation (OIC)",
      "Pneumonia",
      "Pneumonia, Bacterial",
      "Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma, Recurrent Primary Mediastinal Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Refractory Grade 3b Follicular Lymphoma, Refractory Primary Mediastinal Large B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma",
      "Recurrent Small Cell Lung Carcinoma",
      "Renal Cell Carcinoma",
      "Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma",
      "Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC)",
      "Systemic Lupus Erythematosus",
      "Tumor, Breast Cancer",
      "Tumor, Ovarian Cancer",
      "Unspecified Adult Solid Tumor, Protocol Specific",
      "Urinary Bladder Neoplasm, Neoplasm Metastasis",
      "Ventilator Associated Pneumonia, Respiratory Infection, Tracheobronchitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T13:12:02.020124",
    "search_query": "Nektar Therapeutics",
    "url": "https://clinicaltrials.gov/search?term=Nektar+Therapeutics"
  }
}